| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |